agilon health (NYSE:AGL) Stock Price Expected to Rise, Sanford C. Bernstein Analyst Says

agilon health (NYSE:AGL) had its price objective increased by Sanford C. Bernstein from $2.50 to $3.15 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “market perform” rating on the stock. Sanford C. Bernstein’s price objective indicates a potential upside of 6.24% from the company’s current price.

AGL has been the topic of a number of other research reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 price target on shares of agilon health in a research note on Tuesday, November 19th. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research report on Wednesday, October 2nd. Barclays dropped their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Needham & Company LLC assumed coverage on agilon health in a research report on Friday, January 10th. They set a “hold” rating for the company. Finally, Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $4.03.

agilon health Price Performance

AGL opened at $2.97 on Wednesday. The stock has a market cap of $1.22 billion, a P/E ratio of -3.15 and a beta of 0.53. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a fifty day simple moving average of $2.07 and a 200 day simple moving average of $3.67.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter last year, the company earned ($0.06) earnings per share. On average, research analysts expect that agilon health will post -0.59 EPS for the current year.

Insider Buying and Selling

In other agilon health news, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction that occurred on Thursday, December 5th. The stock was acquired at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction on Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently added to or reduced their stakes in AGL. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of agilon health in the third quarter valued at $28,000. Oak Thistle LLC acquired a new position in agilon health in the 4th quarter valued at about $25,000. City State Bank bought a new position in agilon health in the 3rd quarter valued at about $52,000. Quarry LP lifted its position in agilon health by 500.3% during the second quarter. Quarry LP now owns 18,254 shares of the company’s stock worth $119,000 after acquiring an additional 15,213 shares during the last quarter. Finally, Aigen Investment Management LP bought a new stake in shares of agilon health during the third quarter worth approximately $79,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.